CD8+ T Cell Immunity Against a Tumor/Self-Antigen Is Augmented by CD4+ T Helper Cells and Hindered by Naturally Occurring T Regulatory Cells
National Institutes of Health · National Cancer Institute · +10 more institutions
Abstract
CD4(+) T cells control the effector function, memory, and maintenance of CD8(+) T cells. Paradoxically, we found that absence of CD4(+) T cells enhanced adoptive immunotherapy of cancer when using CD8(+) T cells directed against a persisting tumor/self-Ag. However, adoptive transfer of CD4(+)CD25(-) Th cells (Th cells) with tumor/self-reactive CD8(+) T cells and vaccination into CD4(+) T cell-deficient hosts induced autoimmunity and regression of established melanoma. Transfer of CD4(+) T cells that contained a mixture of Th and CD4(+)CD25(+) T regulatory cells (T(reg) cells) or T(reg) cells alone prevented effective adoptive immunotherapy. Maintenance of CD8(+) T cell numbers and function was dependent on Th…
Citation impact
- FWCI
- 19.36
- Percentile
- 100%
- References
- 66
Authors
12- PAPaul A. AntonyCorresponding
National Institutes of Health, National Cancer Institute, Center for Cancer Research
- CACiriaco A. Piccirillo
McGill University
- AAAkgül Akpınarlı
National Institute of Allergy and Infectious Diseases
- SESteven E. Finkelstein
National Institutes of Health, National Cancer Institute, Center for Cancer Research
- PJPaul J. Speiss
National Institutes of Health, National Cancer Institute, Center for Cancer Research
Topics & keywords
- IL-2 receptor
- Cytotoxic T cell
- Adoptive cell transfer
- Interleukin 21
- CD8
- Immunology
- Biology
- Immunotherapy
- Good health and well-being